Skip to main content
Article thumbnail
Location of Repository

Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancer

By Shin-ichi Yamashita, Masao Chujo, Michiyo Miyawaki, Keita Tokuishi, Kentaro Anami, Satoshi Yamamoto and Katsunobu Kawahara
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2000). AJ: Surfing the p53 network. Nature
  2. (2002). Arakawa H: p53AIP1 regulates the mitochondrial apoptotic pathway. Cancer Res
  3. (1998). DP: The p53 tumour suppressor gene.
  4. (1993). Hollstein M: Clinical implications of the p53 tumorsuppressor gene.
  5. (2008). Kawahara K: p53AIP1 expression can be a prognostic marker in non-small cell lung cancer. Clin Oncol (R Coll Radiol)
  6. (1999). Kinzler KW: Analysis of human transcriptomes. Nat Genet
  7. (2000). Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res
  8. (1999). Selivanova G: p53-induced apoptosis as a safeguard against cancer. Biochem Biophys Res Commun
  9. (1998). Tanigawa N: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res
  10. (2000). Taya Y: p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell
  11. (1999). The cellular response to p53: the decision between life and death. Oncogene
  12. (2002). Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene
  13. (2003). Validating survivin as a cancer therapeutic target. Nat Rev Cancer
  14. (1999). Vousden KH: Mechanisms of p53-mediated apoptosis. Cell Mol Life Sci
  15. (2006). W: Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk. Cancer Res

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.